Bioactivity:

CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase and has anti-chronic myeloid leukemia (CML) activity.

CAS nr:

1388710-60-8

Purity:

98%

Molecular Weight:

525,04

SMILES:

CC1=CC=C(NC(C2=CC=C([C@@H](N3CCN(C)CC3)CC4)C4=C2)=O)C=C1C#CC5=CN=C6N5N=C(Cl)C=C6

Formula:

C30H29ClN6O

Pathway:

Others

Target:

Others